A new report shows most of the conduct targeted by Indiana’s HIV criminalization laws carry no risk of transmission.

Gilead Sciences (NASDAQ:GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention ...

The National Agency for the Control of AIDS (NACA), on Wednesday, lamented that Ogun State, despite efforts to reduce the ...

Africa, which is home to roughly two-thirds of people living with HIV, is poised to surpass Asia as the continent with the ...

The medication was not available at the facility's pharmacy, but staff did not notify the provider so that new orders could ...

Although sexually transmitted infections are still at an epidemic level in the US, scientists at the US Centers for Disease ...

Gilead Sciences Inc (NASDAQ:GILD) stock is trading higher on Thursday after the company reported better-than-expected ...

The number of sexually transmitted infections (STI) in the United States in 2023 was down nearly 2% from the year before, a ...

Madagascar may soon face an explosion in the incidence of HIV, similar to what it was in southern Africa, TASS reports with ...

Are you a print subscriber? Activate your account. By Garett Sloane - 3 min 8 sec ago By Ewan Larkin - 8 min 31 sec ago By ...

The HIV drug maker reported sales of $7.55 billion, up 7% year over year, beating the consensus of $7 billion, primarily due to higher sales in HIV and Veklury (remdesivir), Oncology and Liver ...

Gilead Sciences Inc (NASDAQ:GILD) stock is trading higher on Thursday after the company reported better-than-expected third-quarter financial results and raised its fiscal year 2024 guidance.